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Remodelling of a polypyrimidine tract-binding protein
complex during apoptosis activates cellular IRESs
HA King1,3,4, LC Cobbold1,3, X Pichon1, T Po¨yry1, LA Wilson1, H Booden1, R Jukes-Jones1, K Cain1, KS Lilley2, M Bushell1
and AE Willis*,1
Post-transcriptional control of gene expression is mediated by the interaction of RNA-binding proteins with their cognate mRNAs
that specifically regulate their stability, localization and translation. mRNA-binding proteins are multifunctional and it has been
proposed therefore that a combinatorial RNA-binding protein code exists that allows specific protein sub-complexes to control
cytoplasmic gene expression under a range of pathophysiological conditions. We show that polypyrimidine tract-binding protein
(PTB) is central to one such complex that forms in apoptotic cells. Thus, during apoptosis initiated by TNF-related apoptosis
inducing ligand there is a change in the repertoire of RNA-binding proteins with which PTB interacts. We show that altering the
cellular levels of PTB and its binding partners, either singly or in combination, is sufficient to directly change the rates of
apoptosis with increased expression of PTB, YBX1, PSF and NONO/p54nrb accelerating this process. Mechanistically, we show
that these proteins post-transcriptionally regulate gene expression, and therefore apoptotic rates, by interacting with and
stimulating the activity of RNA elements (internal ribosome entry segments) found in mRNAs that are translated during
apoptosis. Taken together, our data show that PTB function is controlled by a set of co-recruited proteins and importantly
provide further evidence that it is possible to dictate cell fate by modulating cytoplasmic gene expression pathways alone.
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Introduction
During pathophysiological conditions of stress including viral
infection, amino-acid starvation and apoptosis cells respond
by reprogramming protein synthesis.1 This is brought about by
a reduction in global protein synthesis and, in parallel, the
recruitment of specific mRNAs whose protein products are
required to respond to the stress or execute a particular
cellular process; for example, during apoptosis there is an
increase in the synthesis of proteins that are required for
chromatin remodelling.2
The inhibition of protein synthesis that occurs during cell
stress is achieved by modification of the canonical protein
synthesis machinery (eukaryotic initiation factors) and cells
have therefore developed specialized mechanisms to bring
about the recruitment of selective subsets of mRNAs to
actively translate ribosomes under these conditions. In
general, this is mediated by the interactions of RNA elements
in the 50 and 30 UTRs of mRNAs with their cognate mRNA-
binding proteins/regulatory RNAs.3 Many cis-acting mRNA
regulatory elements that permit selective translation under
different conditions of cell stress have been identified
including internal ribosome entry segments (IRESs)2 and
upstream open reading frames4 in the 50 UTR and miRNA-
binding sites and stability determinants3 in the 30 UTR.
However, relatively few of the trans-acting RNA-binding
protein complexes that are required to recruit mRNAs to the
polysomes have been identified. Interestingly, it has been
suggested that a combinatorial code exists where complexes
comprising of different subsets of RNA-binding proteins are
formed under distinct cellular conditions. It has been
hypothesized therefore that such complexes, by controlling
gene expression post-transcriptionally would be essential for
the full execution of a cellular process.5,6 To address this
question under a defined cell stress condition, we studied the
role of polypyrimidine tract-binding protein (PTB)-dependent
complexes during apoptosis initiated by TNF-related
apoptosis inducing ligand (TRAIL). There were a number of
pertinent reasons for the choice of PTB and its role in
apoptotic cells. First, the known characteristics of PTB would
suggest that it could be a central node in a combinatorial RNA-
binding protein code as it is a multifunctional mRNA-binding
protein with roles in many aspects of post-transcriptional
control of gene expression including alternative splicing,7,8
RNA stability, localization9 and translation.10 Second, PTB is
found in large ribonuclear complexes and several known
binding partners have been identified, for example, PSF and
hnRNPL.11–13 Finally, the IRESs that function during
TRAIL-mediated apoptosis are PTB dependent and we
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hypothesized that such a PTB-containing mRNA-binding
complex would interact with these elements.
Our data suggest that there was substantial remodelling of
PTB-containing complexes in apoptotic cells concomitant with
changes in protein localization. We show that PTB and its
interacting partners influence apoptotic rates suggesting that
cell fate is dictated by these protein complexes. RNA affinity
purification and proteomic analysis identified the proteins that
interacted directly with the IRES elements found in the 50 UTRs
of mRNAs that are known to remain polysomally associated
during apoptosis. Importantly, there was a large degree of
overlap between the proteins that interacted with the IRES
elements and those present within the PTB-containing com-
plexes. Taken together, the data obtained from these large-
scale screens suggest that during TRAIL-mediated apoptosis
there is remodelling of PTB-containing complexes allowing
translation of a subset of PTB-dependent mRNAs whose
protein products are required to execute this process.
Results
PTB-containing complexes are remodelled during apoptosis.
To identify the proteins that interact with PTB and
whether these changes during apoptosis proteomics-based
approaches and western analysis were used.
For proteomic analysis, MCF7 cells were exposed to TRAIL
to initiate apoptosis, and nuclear and cytoplasmic extracts
were generated from either apoptotic or control cells. PTB and
its interacting partners were immunoprecipitated from these
extracts and applied to SDS-PAGE. After separation, samples
were subjected to tandem LC-MS/MS mass spectrometric
analysis; this analysis was repeated on a further two
independent occasions. Both the number of unique peptides
identified for PTB and the immunoblot analysis show that
there was an increase in the amount of PTB in the cytoplasm
during TRAIL treatment, and a corresponding decrease in the
amount of PTB in the nucleus (Figure 1ai), in agreement with
previous data.2,14 These data were confirmed using immuno-
fluorescence and confocal microscopy, and after 3-h TRAIL
treatment cells show a marked increase in the cytoplasmic
concentration of PTB (Figure 1ai).
Tandem LC-MS/MS was then used to identify putative
interacting proteins (Figure 1b and Supplementary Figure
S1A). Complexes formed both in the nucleus and the
cytoplasm were examined because for some RNA elements
it has been suggested that the RNA-binding proteins that
control their cytoplasmic activity are pre-loaded in the
nucleus.15 Immunoprecipitation reactions using antibodies
directed against PTB were then carried out on cell extracts
obtained from MCF7 and HeLa cells treated with TRAIL to
confirm some of these interactions, and moreover to examine
whether the complexes formed were present in cells of
different origin (Figures 1b and c). In the majority of cases, the
interactions identified using tandem LC-MS/MS were con-
firmed by western analysis (Figure 1ci). Taken together, these
data suggest that in the nucleus of control MCF7 cells PTB is
present in a complex that includes the RNA-binding proteins
NONO/p54nrb, PSF, hnRNPA1, hnRNPC1/C2 and hnRNPA2/
B1. Changes in the composition of this complex during TRAIL-
mediated apoptosis were detected by tandem LC-MS/MS
showing there is an increase in the levels of hnRNPC1/C2 and
hnRNPA2/B1 (Figure 1b) although no significant differences
in hnRNPA2/B1 were detected by western blotting
(Figure 1ci). However, both hnRNPC1/C2 and hnRNPA2/B1
were shown to increase with TRAIL treatment in HeLa cell
nuclear fraction (Figure 1cii). DDX3X and YBX1 were
detected in the PTB complex in the nuclear fraction of the
apoptotic MCF7 cells by LC-MS/MS analysis, but this could
not be confirmed by western blot, yet these complexes were
detected in HeLa cells (Figure 1cii).
In the cytoplasm of the control MCF7 cells, PTB was
present in a complex that contains DDX3X and YBX1 and the
amount of both of these proteins were increased with the
TRAIL treatment (Figures 1b and ci). Neither of these proteins
was observed in the PTB complex in the HeLa cell
cytoplasmic fraction (Figure 1cii).
RNAse A was included in immunoprecipitation reactions to
determine whether the association of these proteins with PTB
occurred via direct protein–protein interactions, or indirectly
via an RNA intermediate. However, with exception of NONO/
p54nrb the interaction of all other proteins with PTB was RNA
independent (data not shown).
To confirm that these proteins were able to interact directly
in vitro, recombinant proteins were generated and incubated
at equal molar ratios with rePTB (Figure 1d). The protein
complexes were isolated using an anti-PTB antibody,
separated by SDS-PAGE and immunoblotted with the
antibodies shown. The data showed that recombinant
YBX1, NONO/p54nrb and hnRNPA1 interacted with PTB
in vitro (Figure 1d), confirming the in vivo data, whereas
rePCBP1, which was not identified as part of the PTB
complex, did not interact with rePTB (Figure 1d).
The immunoprecipitation data suggest that during
apoptosis there was a cellular relocalization of PTB-asso-
ciated proteins. Therefore, MCF7 cells were incubated with
TRAIL for 1, 2, 3 or 4 h, lysed and separated into nuclear and
cytoplasmic fractions, applied to SDS-PAGE and immuno-
blotted with the antibodies shown (Figure 2ai). The data
confirmed an increase in the PTB-associated mRNA-binding-
proteins YBX1 and DDX3X during apoptosis. There was also
increase in the cytoplasmic levels of PCBP2, hnRNPA2/B1
and hnRNPC1/C2 at 4-h incubation with TRAIL (Figure 2ai).
HnRNPA1 was shown to relocate from the cytoplasm to the
nucleus at 3 h, notably at the same time point where the
cytoplasmic concentration of PTB increases, this is of interest
because it has been shown previously that hnRNPA1 is a
negative regulator of the Apaf-1 IRES.28 Many of the proteins
identified as part of the PTB-containing complex are known to
have other cellular functions, and therefore not all of the
changes in location/increases in expression will correlate
directly with enhanced association with PTB. To ensure that
apoptosis was occurring, cells were analyzed by Annexin V
labelling and propidium iodide (Figure 2aii)
The PTB-containing complex interacts with a subset of
cellular mRNAs. During apoptosis, reprogramming of the
translational machinery permits a specific subset of PTB-
dependent IRES-containing mRNAs to remain associated
with the polysomes including mRNAs encoding SETD7
(SET7/9), cyclin T1, MTG8A, Apaf-1 and cyp1b1.2
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These mRNAs encode proteins that have a role in the
apoptotic process that include proteins that are central to the
formation of the apoptosome, for example, Apaf-1,16 proteins
that modify transcription factor activity leading to upregula-
tion of proapoptotic target gene transcription, for example,
SETD7,17 and cell cycle regulators, for example, cyclin
T1.18,19 Therefore, to determine whether proteins that formed
part of the PTB-containing complex also interacted with
these IRES elements, RNA affinity purification was used.
Biotinylated RNAs were incubated with HeLa cell extracts
(both nuclear and cytoplasmic) and the protein complexes
isolated (see Materials and methods section). Proteins were
eluted, separated by SDS-PAGE and identified by LC-MS/
MS (Figure 3a, and Supplementary Figures S2A–C); these
experiments were performed on three independent occa-
sions. The data show that a large number of the RNA-binding
proteins that were part of the PTB-containing complex also
interacted with both cyclin T1 and SETD7 50 UTRs
(Figure 3b) and importantly, with other cellular IRESs tested
(Supplementary Figure S2). Thus, the proteomic data show
that cyclin T1 and SETD7 interacted, either directly or
indirectly, with 14 members of the PTB complex including
PTB, hnRNPA1, hnRNPA2/B1, hnRNPK, DDX1, 3X, 5 and
21 and NONO/p54nrb, PSF and YBX1 (Figure 3b). Some
proteins identified are known to stimulate the activity of other
cellular IRESs. For example, hnRNPC1/C2, hnRNPK,
NONO/p54nrb and PSF are required for c-myc IRES-
mediated translation (for reviews, see Komar and
Hatzoglou20 and Spriggs et al.21).
The proteins identified interact with cyclin T1 and SETD7
mRNAs in vitro and in vivo. It was then important to
Figure 1 PTB-containing complex that forms during TRAIL-mediated apoptosis. MCF7 cell were induced to undergo apoptosis via treatment with 0.5 mg/ml TRAIL for 3 h,
then harvested and fractionated to produce nuclear and cytoplasmic lysates. Mock and TRAIL-treated cytoplasmic/nuclear lysates were used in an anti-PTB immunoprecipitation,
which were then analyzed via immunoblotting and LC-MS/MS mass spectrometry. (ai) Western blot with a-PTB antibody. IgG was used as a loading control from the IP reaction.
Number of unique peptides identified for PTB is shown. (aii) Immunofluorescence was used to confirm the relocalization of PTB following TRAIL-treatment. MCF cells±TRAIL for
3 h were stained with a-PTB antibody and observed by confocal microscopy. White bar represents 10mm. (b) Table showing PTB-binding partners identified by LC-MS/MS mass
spectrometry. A color scale is used to illustrate the number of unique peptides. Number of plus (e.g., þ /þ þ /þ þ þ ) are used to represent the relative abundance of each
species detected. (ci) Western blotting of the control and TRAIL treated MCF7 cell lysates was performed using antibodies to the indicated proteins to investigate PTB-interacting
partners. (cii) The immunoprecipitations of PTB and its interacting partners were then repeated in HeLa cells. Western blotting of control and TRAIL treated HeLa cell lysates was
performed using antibodies to the indicated proteins to investigate PTB-interacting partners in this cell type. (d) RNA-independent association of the different PTB partners were
confirmed by carrying out anti-PTB immunoprecipitations in vitro following incubation of recombinant-PTB (rePTB) with rePCBP1, re-hnRNPA1, reNONO, rePCBP2 and reYBX1.
Western blot using antibodies to the indicated proteins is shown; IgG was used as a loading control
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determine whether these proteins interacted directly with
cellular IRESs (Figure 4 and Supplementary Figure S3) and,
where appropriate, the strength of these interactions
(Figure 4). Thus, radiolabelled IRES RNA was generated
and filter-binding assays were carried out with PTB, PSF,
NONO/p54nrb, hnRNPA1, hnRNPA2, hnRNPK, PCBP2, YBX1
and DDX3X singly and in some cases in combination
(Figure 4a and Supplementary Figure S3A). With the exception
of NONO/p54nrb and hnRNPA2 all proteins interacted directly
with the cyclin T1 IRES, albeit to different extents. SETD7
IRES interacted with all proteins with the exception of NONO/
p54nrb, DDX3X or PCBP2, suggesting that these proteins were
identified because of their direct interaction with PTB
(Figure 1). Remodelling of IRES structures to achieve binding
of individual trans-acting factors often requires additional
proteins22,23 and interestingly, the data show that only when
combined with PSF (which was kept constant during the
experiment) NONO/p54nrb was able to interact with the IRES
RNA (Figure 4a and Supplementary Figure S3A). Although
NONO/p54nrb interacts with PTB in vitro (Figure 1d), this
reaction was found to be partially RNA dependent. Taken
together, these data (Figure 4) suggest that NONO/p54nrb
interacts with both PTB, and PSF in vivo.
To determine whether some of these proteins interacted
with endogenous SETD7, cyclin T1, MTG8A and CYP1b1
RNA in vivo mRNA immunoprecipitation reactions were
carried out (Figure 4b; right-hand panel shows that the
proteins were immunoprecipitated as expected, and
Supplementary Figure S3B). Cell lysates were incubated with
antibodies directed against NONO/p54nrb, PSF or PTB and
mRNAs that co-immunoprecipitated with these complexes
were reverse transcribed and the cDNAs used in qPCR. The
data show that all mRNAs were significantly enriched in the
complexes that were immunoprecipitated using antibodies
directed against, PSF, NONO/p54nrb and PTB compared with
controls (Figure 4b and Supplementary Figure S3B).
Cellular IRES function is regulated by the PTB-containing
complex. To determine whether these proteins affected
IRES-mediated translation from these mRNAs, vectors that
contained the cyclin T1 or SETD7 IRESs fused in frame with
DNA encoding Firefly luciferase and an upstream hairpin to
block ribosome scanning (Figure 5a) were transfected into
HeLa cells. The levels of hnRNPA1, NONO/p54nrb, PSF,
PTB and nPTB and YBX1 were reduced and luciferase
activity was determined (Figure 5b). The data show that in
cells where there is a reduction in PTB and YBX1 expression,
IRES function of cyclin T1 was reduced to approximately
70% of the control cell value with a smaller, but significant
decrease of SETD7 IRES activity. Decreasing expression of
PSF or NONO/p54nrb alone, or in combination, had little or no
significant effect on IRES activity. However, when levels of
PTB, PSF and NONO/p54nrb were simultaneously reduced,
cyclin T1 and SETD7 IRES activity was inhibited about 50%
(Figure 5bii). Similar effects were observed with the other
apoptotic IRESs tested (Supplementary Figure S4B).
A reduction of hnRNPA1 levels was shown to stimulate all
the IRESs tested suggesting that this protein functions as an
inhibitor of apoptotic IRES activity (Figure 5bii and
Supplementary Figure S4B). Little effect was observed when
DDX3X, hnRNPA2/B1 or PCBP2 protein levels were reduced
(data not shown).
We hypothesize that relocation of IRES-binding proteins to
the cytoplasm of apoptotic cells is required to stimulate IRES
function. Therefore, to mimic this situation in vitro, rabbit
reticulocyte lysates were used that were primed with IRES-
containing mRNAs and the proteins identified as part of the
PTB complex, were added either singly or in combination.
Reticulocyte lysates already contain significant amounts of
some of these proteins, therefore it was not expected that all
of these proteins would give a large stimulation.24 However,
PSF and NONO/p54nrb and PTB stimulated the cyclin T1 and
there was a greater stimulation when PSF and NONO/p54nrb
Figure 2 Relocalization of members of the PTB complex during apoptosis. (ai) Western blotting of nuclear and cytoplasmic fractionated lysates of MCF7 cells treated with
TRAIL over a 4 h time course using antibodies against indicated proteins. RPS6 and Lamin A/C antibodies were used as cytoplasmic and nuclear markers, respectively. PARP
cleavage was used to indicate apoptosis and b-actin was used as a loading control. (aii) Control and TRAIL-treated MCF7 cells were stained with Annexin V-FITC and
propidium iodide at the indicated time points and subjected to FACS analysis. Staurosporin-treated MCF7 cells (STS) served as a positive control at 6 h
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were added in combination (Figure 5c). Interestingly,
hnRNPA1 repressed IRES activity with a small, but significant
reduction in the amount of luciferase produced (Figure 5c).
Similar effects were observed with the SETD7 IRES
(Figure 5c) and the other IRESs tested suggesting that the
proteins identified are required for IRESs that function during
apoptosis (Supplementary Figure S4A).
Proteins in the PTB-containing complex control the
apoptotic rate. To determine whether the proteins identified
within this complex were able to directly influence the rate of
apoptosis in cells treated with TRAIL, cells were transfected
with vectors allowing for the overexpression of NONO/p54nrb,
PSF and PTB or with the corresponding siRNAs to reduce
their expression (Figures 6ai and bi). These cells were then
incubated with TRAIL for 6 h, harvested and stained with
Annexin V and propidium iodide before being subjected to
flow cytometry to determine the degree of apoptosis.
Following exposure to TRAIL, 40% of the control cells
underwent apoptosis at 6 h. PSF, PTB or PTBþPSFþ
NONO/p54nrb overexpression resulted in a greater degree of
apoptosis, 6 h after treatment with TRAIL (Figure 6aii).
In contrast, depletion of PSF, PTB or PTBþPSFþNONO/
p54nrb reduced cell death with 15–20% apoptosis occurring
compared with 50% observed in the control cells
(Figure 6bii). These data illustrate that altering the levels of
Figure 3 IRES RNA affinity analysis. (a) In all, 50mg of biotin-tagged cyclin T1 and SETD7 5’ UTRs or 300 nt RNA of GAPDH coding region was used as bait to purify
IRES-binding proteins from HeLa cell lysate in a binding buffer (10 mM Tris pH 7.5, 25 mM KCl, 2 mM MgCl2, 0.02% Tween-20, 1 mM ATP, 1 mg/ml yeast tRNA, 1 mg/ml
heparin, RNase inhibitor, 1 protease inhibitor) for 60 min at 4 1C. Streptavidin-conjugated magnetic beads (Invitrogen) were added and incubated for a further 30 min.
The bound complexes were washed with buffers that contained increasing salt concentration and eluted samples were applied to SDS-PAGE and stained with colloidal
Coomassie blue and silver. Proteins that were specifically eluted from the cyclin T1 or SETD7IRESs, but not the GAPDH are marked (*). (b) Proteins bound to each RNA were
identified firstly via LC-MS/MS mass spectrometry (Supplementary Figures S2A and B) and then via immunoblotting analysis (Supplementary Figure S2C).
The table shows proteins, which were identified as binding to either or both of the cyclin T1 and SETD7 IRESs, whereby a plus indicates binding, in either the mass
spectrometry data, the immunoblotting data or both. The proteins included in the table are those found to be both IRES binding and PTB associated
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these RNA-binding proteins alone is sufficient to modulate
apoptosis rates and strongly suggest that the PTB-containing
complex is important for this process to proceed efficiently.
The PTB-containing complex interacts with the cyclin T1
IRES in the nucleus. We have shown previously that
certain cellular IRESs, in contrast to viral IRESs such as
encephalomyocarditis virus (EMCV) and hepatitis C virus
(HCV), are inactive when IRES-containing RNAs are
transfected into the cytoplasm and require a ‘nuclear event’
before they are fully functional.15 Our data show that a
‘remodelled’ PTB-containing complex is present in both the
nucleus and the cytoplasm of apoptotic cells. To test whether
there was nuclear activation of IRESs in apoptotic cells rather
than direct cytoplasmic activation, DNA constructs and
in vitro transcribed reporter RNAs containing the cyclin T1
IRES were used. As controls, RNAs that contained the HCV
IRES, which binds PTB, but is not dependent on PTB for
function10 and the EMCV IRES that binds to PTB and whose
activity is stimulated by this protein25,26 were used. There
was activation during apoptosis of the EMCV IRES with both
RNA and DNA transfection (presumably because the levels
of PTB that activates this IRES increase in the cytoplasm in
apoptotic cells; Figure 1a). There was no stimulation of HCV
IRES activity, as expected, and the cyclin T1 IRES was only
activated following DNA transfection (Figure 6c).
Therefore, we hypothesize that the complex that contains
PTB is remodelled in the nucleus of apoptotic cells
and interacts with IRESs in cellular mRNAs that encode
proteins that function during apoptosis, providing the ‘nuclear
event’. In the cytoplasm, recruitment of additional factors are
necessary to permit a fully functional mRNA protein complex
that is recruited to the polysomes and translation is initiated
(Figure 7).
Figure 4 Members of the PTB-containing complex bind apoptotic IRES RNA in vitro and in vivo. Binding of the identified complex members to the apoptotic IRES RNA was
validated by a number of methods. (a) UV-crosslinking (right panels) and filter-binding assays (left panels) using 32P-labelled cyclin T1 or SETD7 5’ UTR. (ai) 32P-CTP-labelled
cyclin T1 and rePTB, rePSF and rePCBP2 or (aii) 32P-CTP-labelled SETD7 RNA with rePTB, rePSF and reYBX1 were used in UV-crosslinking and filter-binding assays.
Specificity of the binding was demonstrated by increasing the amount of cold competitor IRES RNA (right panel), or nonspecific control RNA (left panel). The UV-crosslinked
signal was quantified relative to the central no competitor RNA lane, which was set to a 100. (aiii) Dissociation constants for each protein/RNA combination were calculated in
the filter-binding assay. A constant level of the 32P-labelled probe was used over a range of molarity of each recombinant protein. S.D. is shown in square brackets, and the
data are the average of three repeats. (b) Binding of endogenous PTB, PSF or NONO/p54nrb to the IRES RNA was shown using RNA-IP with antibodies against the proteins
indicated, followed by RT-qPCR using primers specific for cyclin T1, SETD7 or control RNA. 15 cm confluent plates of HeLa cells were lysed in lysis buffer (20 mM HEPES
pH7.2, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, RNAsin 400 U/ml, 0.5% Triton X-100 and protease inhibitors), incubated for 5 min at 4 1C and centrifuged to pellet the nuclei.
The post-nuclear extract was incubated with PTB, PSF or NONO/p54nrb antibodies or IgG (control) coated protein A beads for 1 h at 4 1C. Beads were washed 4 30 min with
buffer A (20 mM Hepes pH 7.2, 200 mM NaCl, 5 mM MgCl2, 0.5% Triton X-100, 1 mM DTT) and 2with buffer B (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM MgCl2 and 0.05%
NP40). Beads containing protein-RNA complexes were isolated and re-suspended in 200ml buffer B and proteinase K treated for 45 min at 55 1C. The RNA was isolated by
phenol/chloroform extraction and quantified by RT-qPCR using primers specific for cyclin T1, SETD7 or control RNA. Results are shown relative to a nonspecific IgG
immunoprecipitation. Western blot of the IPs using antibodies against proteins indicated is shown on the right. Significance (*Po0.05, **Po0.01 or ***Po0.005) was
calculated using an unpaired two-tailed Student’s t-test (n¼ 3), error bars represent S.D.
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Figure 5 Altering the levels of PTB-interacting proteins effects IRES activity. (a) Schematic representation of the monocistronic constructs used in figures bii and c, which
contains a stable hairpin loop downstream of the 50 m7G cap in order to inhibit cap-dependent translation of the Firefly luciferase reporter. (bi) HeLa cells were co-transfected
with siRNA against the indicated proteins together with the monocistronic reporter plasmid, incubated for 48 h then harvested and western blot analysis was carried out to
confirm RNAi success. Immunoblots are quantified relative to b-actin levels, and expressed as a percent of levels in the control siRNA treated lysate. (bii) Luciferase assays
were carried out on the RNAi lysates. Data are shown relative to a control experiment using control siRNA. Significance (*Po0.05, **Po 0.01 or ***Po0.005) was calculated
using an unpaired two-tailed Student’s t-test (n¼ 3), error bars represent S.D. (c) Reticulocyte lysates were primed with 100 ng recombinant protein and 100 ng of in vitro
transcribed m7G capped and polyadenylated reporter RNA, incubated at 30 1C for 90 min, then assayed for luciferase activity. Data are shown relative to a control experiment
with no recombinant protein added. Significance (*Po0.05, **Po0.01 or ***Po0.005) was calculated using an unpaired two-tailed Student’s t-test (n¼ 3), error bars
represent S.D.
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Discussion
It is clear from the study of a number of systems, that mRNA-
binding proteins have a crucial role in the post-transcription
regulation of gene expression. For example, HuR and its
neuronal relatives (HuB, HuC and HuD) associate with
numerous mRNAs encoding proteins with a wide range of
cellular roles including division, survival, immune response
and differentiation, and influence their stability and synth-
esis.27 HuR does not act in isolation and interplay of HuR with
other proteins and miRNAs is necessary to obtain specificity
of interaction with these mRNAs.28
Similarly, PTB is also known to interact with mRNAs that
encode proteins with a diverse range of functions9 and some
of its binding partners have been identified.13 However, the full
complement of mRNA-binding proteins with which it associ-
ates has not been previously addressed. We therefore
examined the PTB-containing complexes that form in control
and apoptotic cells and addressed whether they interact with
RNA elements present in mRNAs that are translated during
Figure 6 Altered expression of PTB-binding proteins controls apoptotic rates. (a) Overexpression of PTB1, NONO/p54nrb, PSF either individually or together enhances
TRAIL-induced apoptosis. (ai) MCF7 cells were transfected with pcDNA3.1, pcDNA3.1-PTB1, pcDNA3.1-NONO/p54nrb, pcDNA3.1-PSF, pcDNA3.1-YBX1 plasmids and
subjected to 6-h TRAIL treatment. The overexpression was assessed by western blot using antibodies against the proteins indicated. Immunoblots were quantified relative to
b-actin levels and expressed as a percent of levels in the control cells. (aii) FACS analysis of MCF7 cells overexpressing the proteins above. After TRAIL treatment, cells were
stained with Annexin V-FITC and propidium iodide and subjected to FACS analysis. Significance (*Po0.05) was calculated using an unpaired two-tailed Student’s t-test
(n¼ 3) relative to the control. (b) Depletion of endogenous YBX1, PTB, NONO/p54nrb and PSF individually or in combination protected cells against TRAIL-mediated
apoptosis. (bi) Western blot of siRNA treated MCF7 cells using antibodies indicated. Immunoblots were quantified relative to b-actin levels and expressed as a percent of
levels in the control cells. (bii) FACS analysis of siRNA treated MCF7 cells treated as in aii. Significance (*Po0.05) was calculated using a paired two-tailed Student’s t-test
(n¼ 3) relative to the control. (ci) MCF7 cells were transfected via nucleofection with dicistronic pRIRESF plasmid, incubated for 48 h before mock or TRAIL treatment for 4 h.
Both protein and RNA were harvested. Firefly luciferase counts were normalized to total protein, and luciferase RNA levels were normalized to GAPDH RNA. The translation
efficiency is expressed as Firefly luciferase activity/mRNA level. Data are presented relative to this value for pRF in the mock condition. Western blot with aPARP was
performed to monitor the degree of apoptosis. Significance (*Po0.05) was calculated using an unpaired two-tailed Student’s t-test (n¼ 3), error bars represent S.D. (cii) In all,
1mg of capped and polyadenylated mRNA was transfected into MCF7 cells, incubated for 2 h before mock or TRAIL-treatment for a further 4 h. Cells were harvested and
assayed for both Renilla and Firefly luciferase. Firefly luciferase counts were normalized to Renilla luciferase counts and are presented relative to RF in the mock condition.
Significance (***Po0.01) was calculated using an unpaired two-tailed Student’s t-test (n¼ 5), error bars represent S.D.
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apoptosis (Figures 1 and 2, Supplementary Figures S2–S4).
Our data strongly suggest that a PTB-containing complex is
remodelled during TRAIL-mediated apoptosis to form
one that contains PSF, YBX1, NONO/p54nrb, hnRNPA2/B1,
hnRNPC1/C2 andDDX3X (Figures 1a–c). Interestingly, some
of these proteins have been shown previously to be involved
in the translation of mRNAs that contain IRES elements.29–31
The data also suggest that remodelling of this complex during
apoptosis is achieved, in part, by a relocalization of these
proteins, with PTB, YBX1, NONO/p54nrb, hnRNPA2/B1 and
hnRNPC1/C2 showing an increase in their cytoplasmic
localization during TRAIL-mediated apoptosis (Figure 2ai),
whereas hnRNPA1 that has been shown to inhibit the
translation of the Apaf-1 IRES32 becomes more nuclear in
its localization (Figure 2ai).
Using RNA affinity-based approaches, we show that
proteins in the PTB-containing complex interacted with the
highly active cyclin T1 and SETD7 IRESs (Figures 3 and 4), in
addition to those in MTG8a and cyp1b1 (Supplementary
Figures S2–S3). Moreover, either singly or in combination
they affect IRES activity both positively and negatively
(Figure 5, Supplementary Figure S4). Importantly, we show
that by modifying the expression of these proteins alone, it is
possible to control cell fate (Figures 6a and b). Thus,
overexpression of the proteins that form part of the PTB-
containing complex increases the rate of apoptosis while
reducing their expression delays this process (Figures 6a and b).
Given the number of protein factors that are required, these
cellular IRESs clearly differ markedly from viral IRESs that
require relatively few, or in some cases, no trans-acting
factors.33 This is probably due to inherent differences in the
stability of the structures formed by viral IRES RNAs
compared with cellular IRES mRNAs, and in turn this is likely
to reflect the very different circumstances under which these
types of motifs are used to initiate translation. The data
suggest that protein complexes act as chaperones to remodel
the IRES RNAs into structures that are able to recruit the
ribosome, whereas, in contrast, highly structured viral IRESs
are already competent in this regard.34 For example,
compactly folded IRESs found in the IGR of the dicistroviridae
family are able to bind the 40S subunit via stable pseudoknots,
with the first pseudoknot occupying the P-site such that the
40S subunit is positioned correctly for elongation.35 Moreover,
as initiation of translation on mRNAs that contain cellular
IRESs can also frequently occur via scanning (e.g., c-Myc is
translated by both mechanisms),15 and cellular IRESs are not
functional during all physiological situations, these elements,
by necessity, are more likely to have flexible structures that
require chaperones for activity.34 Interestingly, in yeast and
Drosophila there is an inverse correlation between IRES
function and structure.36 The lack of structural conservation,
even between IRESs that are found in mRNAs that have
similar functions (e.g., theMyc family of IRESs), suggests that
they have evolved in a very different way from viral
IRESs.34,37–39 Therefore, regulating the recruitment of
specific subsets of RNA-binding proteins to remodel the
structure of cellular IRES into an ‘active mode’ would permit
the control of translation of the corresponding mRNAs as, and
when, required. Controlling the bioavailability of these factors
or the formation of complexes in which they reside, would
directly regulate cytoplasmic control of gene expression in the
absence of transcriptional control. Taking these factors into
account, it is perhaps unsurprising that IRES-mediated
translation on cellular mRNAs is a very complex process
requiring many RNA-binding proteins, in addition to some
canonical initiation factors.20,30,34,40
We hypothesize, therefore, that for full activity it is
necessary for the IRES elements to associate with the PTB-
containing complexes in the nucleus (Figure 7) in support of
previous data, which show that many cellular IRESs require a
‘nuclear event’ before they are fully active.15 It is interesting to
note that many of the proteins identified also function in
splicing41 and one possibility is that these proteins become
associated with the IRES-containing mRNA during splicing.
Indeed, many factors that have a primary role in splicing have
also been shown to directly regulate translation. For example,
SFRS1 promotes mRNA association with polysomes by
modifying 4EBP1 activity.42,43
In summary, our data suggest a model whereby altering the
repertoire of mRNA-binding proteins present in a PTB-
containing complex in the nucleus of apoptotic cells allows
their interaction with specific mRNAs, and influences their
translation thus permitting post-transcriptional control of gene
expression.
Materials and Methods
Plasmid constructs. The dicistronic constructs RcT1F, Rset7F and R1b1F
are described in Bushell et al.2 RMTG8F is described in Mitchell et al.22 The
monocistronic constructs were cloned from the dicistronic constructs using SpeI
and NcoI restriction enzymes and cloned to phpL.40 The mammalian expression
Figure 7 A model to illustrate how formation of a nuclear mRNP containing the PTB complex could be required for cellular IRES activity. Our data suggest remodelling of a
PTB-containing complex occurs following treatment with the apoptosis-inducing ligand TRAIL. Thus, the IRES-inhibitory protein hnRNPA1 decreases in association with PTB,
whereas the IRES-stimulatory proteins NONO/p54nrb, PSF and hnRNPA2/B1 increase in association. This complex then binds to the IRES RNA, and shuttles to the cytoplasm as an
mRNP. Here, further IRES-stimulatory proteins including DDX3X and YBX1 are recruited to the complex, which is then competent to stimulate apoptotic IRES-mediated translation
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constructs of NONO/p54nrb, PSF and PTB in pcDNA3.1-vector have been
described in Cobbold et al.30
Protein expression. Recombinant hnRNPA1, NONO/p54nrb, PCBP1,
PCBP2, PTB and YBX1 were expressed and purified as described.30
Cell culture, TRAIL treatment and transfections. MCF7 and HeLa
cells were maintained in DMEM supplemented with 10% FBS and 2 mM
L-glutamine. Cells were treated with 0.5mg/mlTRAIL (PeproTech, Rocky Hill, NJ,
USA) for times indicated in the figure legends and harvested to produce either
whole cell, or nuclear and cytoplasmic lysates.
Plasmid DNA and mRNA transfections. DNA transfections in HeLa
cells were carried out using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
following the supplier’s instructions. DNA transfections in MCF7 cells were
performed using nucleofector AmaxaV kit (Lonza, Ko¨ln, Germany), using 2 106
cells/1.5mg plasmid/transfection following the supplier’s instructions.
Reporter assays. The activity of Firefly luciferase (monocistronic reporter
vectors) or Firefly and Renilla luciferases (dicistronic reporter vectors) in lysates
prepared from transfected cells were measured using a Luciferase Reporter Assay
System or with Dual-Luciferase Reporter Assay System (Promega, Madison, WI,
USA), and light emission was measured over 10 s using an OPTOCOMP I
luminometer (MGM Instruments, Hamden, CT, USA).
RNA interference. Dharmacon (Waltham, MA, USA) on-target pre-designed
siRNA were used to knockdown levels of NONO/p54nrb, PSF, YBX1 and hnRNPA1.
Levels of PTB1 and nPTB were depleted using siRNAs of sequences:
CUUCCAUCAUUCCAGAGAA.dT.dT and GAGAGGAUCUGACGAACUA.dT.dT.
Dharmacon control siRNA (C3; UGGUUUACAUGUUUUCUGA) was used in control
transfections. Transfections were carried out in 24-well plates or 15 cm plates using
either Dharmafect duo (for dual siRNA and reporter plasmid transfections of HeLa
cells) or Amaxa nucleofection (for siRNA-mediated knockdown in MCF7 cells). Cells
were harvested after 48 or 72 h in the case of YBX1 knockdown cells.
Preparation of cytoplasmic and nuclear lysates. Cells were pelleted
by centrifugation at 4 1C at 250 g for 2 min, then resuspended in (10 mM
HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 50 mM
sodium fluoride, 50 mM glycerol-2-phosphate, 1 protease inhibitor and 0.5%
NP40). Samples were centrifuged to obtain cytoplasmic fraction. The nuclei pellet
was resuspended in (20 mM HEPES pH 7.9 400 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 50 mM sodium fluoride, 50 mM glycerol-2-phosphate, 1
protease inhibitor) and lysates generated.
Western blot and antibodies. Membranes were probed with the following
antibodies: b-actin (Sigma-A5441; Sigma Aldrich, Gillingham, UK); cyclin T1
(Abcam-755105, Cambridge, UK); DDX3X (Abcam-37160); GAPDH (Cell
Signalling-2118; Cell Signalling Technology, Danvers, MA, USA); hnRNPA1
(Abcam-4791); hnRNPA2/B1 (Abcam-6102); hnRNPC1/C2 (Abcam-10294); Lamin
A/C (Cell Signalling-2032); NONO/p54nrb (Abcam-70335); PARP (Cell Signalling-
9532); PCBP2 (Abcam-96169); PSF (Abcam-99357); PTB (BB7), gift from
Professor C Smith, University of Cambridge; nPTB (in house); RPS6 (Cell
Signalling-2217); SETD7 (Cell Signalling-2825); and YBX1 (Abcam-12148).
Immunoprecipitation with a-PTB. Protein A/G beads were pre-bound to
500ml monoclonal anti-PTB antibody (BB7) and incubated with cell extracts.
Proteins were eluted in SDS-PAGE loading dye. For the RNase-treated samples,
an additional incubation in 10mg/ml RNase A at 37 1C for 30 min was included
before protein elution.
Confocal microscopy. MCF7 were seeded onto 13 mm coverslips then
treated with 0.5mg/ml TRAIL for 3 h. Cells were fixed using 4% paraformaldehyde
and permeabilized using 0.1% Triton-X-100. Incubation with primary BB7 anti-PTB
antibody was carried out at a concentration of 1 : 1000, followed by incubation with
fluorophore-conjugated anti-mouse secondary antibody at a concentration of
1 : 200. Finally, cells were incubated in Hoechst stain for 1 h at RT, mounted and
viewed on a Zeiss confocal microscope (Zeiss, Cambridge, UK).
FACS analysis. In all, 1 106 MCF7 cells were transfected with either non-
targeting siRNA or siRNA targeted to PTB1/nPTB, PSF, NONO/p54nrb, YBX1 or
hnRNPA1. After 48 h, cells were treated with 0.5mg/ml TRAIL over a 0–6 h time
course. Cells were trypsinized and stained with Annexin FITC and propidium
iodide. Cells were then subjected to FACS analysis on a BD Biosciences
FACSCalibur (BD Biosciences, Oxford, UK).
RNA affinity purification. Briefly, biotinylated RNA was incubated with HeLa
cell lysates (4C, Mons, Belgium) and the complexes purified on streptavidin-
conjugated magnetic beads (Invitrogen). Eluted proteins were precipitated using
10% TCA and solubilized in SDS-PAGE loading dye (see Figure legend 3a for
further details).
Immunoprecipitation using purified proteins. In all, 100 ml A/G
sepharose beads bound to monoclonal anti-PTB antibody (BB7) were
used to immunopreciptate PTB protein and its interacting partners that
were incubated in an equal molar ratio. The beads were pelleted by
centrifugation and after extensive washing proteins eluted in SDS-PAGE
loading dye.
Filter-binding assays. Approximately 23 000 c.p.m. of labelled transcript
was added to 10ml of buffer mix containing 2ml of 5 transcription buffer
(200 mM Tris-HCl [pH 8.0], 40 mM MgCl2, 10 mM spermidine, 250 mM NaCl)
0.75ml of 1 M DTT, 2ml of tRNA (10 mg/ml), 1ml of 10 mM rATP, and 40 U of
RNasin. Recombinant proteins between the range of 0.050 and 2 mg were then
incubated with the mixture at room temperature for 10 min. Reaction mixtures
were filtered through a nitrocellulose membrane, the membranes were washed, air
dried and counted in a scintillation counter. Values for dissociation constants were
determined from the scintillation readings, whereby the angle of the slope of the
graph is equal to 1/Kd.
UV-crosslinking. In all, 50 000 c.p.m. of 32P-CTP-labelled RNA was used
with 200 nM of protein in a final volume of 20ml (10 mM HEPES pH 7.4, 3 mM
MgCl2, 100 mM KCl, 5 mM creatine phosphate, 1 mM DTT, 1 mM ATP, 6% glycerol
and 0.1mg/ml tRNA) were incubated at room temperature for 15 min with or
without 1 , 5 or 10molar excess of cold competitor RNA (nonspecific
competitor was transcribed from Firefly luciferase gene). In total, 0.05mg/ml
heparin was added and incubated for a further 15 min. The samples were
subjected to UV radiation of 275 J/m2 for 30 min on ice. RNase cocktail (0.1 mg/ml
RNase A, 0.1 mg/ml RNase T1, 0.1 mg/ml RNase V1) was added and incubated at
37 1C for 30 min before SDS-PAGE loading dye was added, samples were run on
a SDS-PAGE gels, fixed, dried and exposed to a phosphorimager screen
(PhosphorImager, Storm, GE Healthcare, Chalfont St Giles, UK).
RNA immunoprecipitations. These were carried out as described
previously.30 More details can be found in the figure legend of Figure 4b.
Reverse transcription and qPCR. Reverse transcription was carried out
using 5mg RNA and with either oligo(dT) or random priming using Superscript III
Reverse Transcriptase System using standard protocol (Invitrogen). QPCR was
carried out in a 50ml reaction containing 5 pmol/ml of each primer, 25ml Syber
Green master mix (Qiagen, Hilden, Germany) and 0.5ml cDNA in each optical
tube. Reactions were carried out in an Applied Biosystems Real-Time PCR
machine (Applied Biosystems, Cheshire, UK). Primers to cDNAs were designed
according to sequences from the NCBI database and relative quantification was
made against IgG control bound beads. All PCR reactions were carried out in
triplicate. Primers (50–30) used for cyclin T1, (F) CCGAGAGCA
CAAAGAAAAGC and (R) GGCTACTATGTTTTGGATCACCAGG; SETD7,
(F) GAAGATTGCCCACCAAAGGAACTG and (R) GCAAGCCATCTTTCTCCT
GAAGAC; MTG8, (F) GCCCAGCAGCAGGGAGACAC and (R) GAAGG
GGTTCCCGGGGTGGT; CYP1b1, (F) CAGCCCACTCAGCCCACTGC and (R)
AGAGGTGGTGGCCGGGGTTT; actin, (F) CGACAACGGCTCCGGCATGT and
(R) TGGGCCTCGTCGCCCACATA; Firefly luciferase, (F) ATGGAAGACGC
CAAAAACAT and (R) GCCTTATGCAGTTGCTCTCC.
In vitro transcription and translation reactions. Capped mRNA was
generated using with the RiboMAX Large Scale Production System-T7 (Promega)
and poly-A tailed with Poly(A) tailing Kit (Ambion, Austin, TX, USA) according to
the manufacturer’s instructions. In vitro translation reactions were performed using
the Flexi rabbit reticulocyte lysate system (Promega). Reactions contained 100 ng
capped RNA template in a final volume of 12.5ml. Protein factors were added at
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80–150 nM. Reactions were incubated at 37 1C for 1.5 h before measurement of
luciferase activity.
Mass spectrometry. Samples were resolved via SDS-PAGE and sliced into
1–1.5 mm slices, before being subjected to in-gel trypsinolysis and analyzed via
nanoLC-MS/MS as described previously.44 Protein and peptide identification were
carried out using the MASCOT programme and validated using scaffold (Proteome
Software Inc., Portland, OR, USA).
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. This research was funded by grants from the Wellcome
Trust (HAK and XP), BBSRC (LCC, and studentship to HB) and CRUK (Lindsay
Wilson) and programme grant funding from the MRC (TP, AEW and MB). AEW
holds a BBSRC Professorial Fellowship and MB a MRC senior fellowship.
1. Spriggs KA, Bushell M, Willis AE. Translational regulation of gene expression during
conditions of cell stress. Mol Cell 2010; 40: 228–237.
2. Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC et al.
Polypyrimidine tract binding protein regulates IRES-mediated gene expression during
apoptosis. Mol Cell 2006; 23: 401–412.
3. Pichon X, Wilson LA, Stoneley M, Bastide A, King HA, Somers J et al. RNA binding protein/
RNA element interactions and the control of translation. Curr Protein Pept Sci 2012; 13:
294–304.
4. Powley I, Kondrashov A, Young LA, Dobbyn HC, Hill K, Cannell IG et al. Translational
reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective
recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev 2009;
23: 1207–1220.
5. Brown V, Jin P, Ceman S, Darnell JC, O’Donnell WT, Tenenbaum SA et al. Microarray
identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in
fragile X syndrome. Cell 2001; 107: 477–487.
6. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 2007;
8: 533–543.
7. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon YS et al. Genome-wide analysis of PTB-RNA
interactions reveals a strategy used by the general splicing repressor to modulate exon
inclusion or skipping. Mol Cell 2009; 36: 996–1006.
8. Llorian M, Schwartz S, Clark TA, Hollander D, Tan LY, Spellman R et al. Position-
dependent alternative splicing activity revealed by global profiling of alternative splicing
events regulated by PTB. Nat Struct Mol Biol 2010; 17: 1114–U1112.
9. Sawicka K, Bushell M, Spriggs KA, Willis AE. Polypyrimidine-tract-binding protein: a
multifunctional RNA-binding protein. Biochem Soc Trans 2008; 36: 641–647.
10. Mitchell SA, Spriggs KA, Bushell M, Evans JR, Stoneley M, Le Quesne JP et al.
Identification of a motif that mediates polypyrimidine tract-binding protein-dependent
internal ribosome entry. Genes Dev 2005; 19: 1556–1571.
11. Shav-Tal Y, D Z. PSF and p54(nrb)/NonO–multi-functional nuclear proteins. FEBS Lett
2002; 531: 109–114.
12. Huttelmaier S, Illenberger S, Grosheva I, Ru¨diger M, Singer RH, Jockusch BM et al. Raver
1 a dual compartment protein is a ligand for PTB/hnRNP1 and microfilament attachment
proteins. J Cell Biol 2001; 155: 755–785.
13. Hahm B, Cho OH, Kim JE, Kim YK, Kim JH, Oh YL et al. Polypyrimidine tract-binding
protein interacts with HnRNP L. FEBS Lett 1998; 425: 401–406.
14. Xie JY, Lee JA, Kress TL, Mowry KL, Black DL. Protein kinase A phosphorylation
modulates transport of the polypyrimidine tract-binding protein. Proc Natl Acad Sci USA
2003; 100: 8776–8781.
15. Stoneley M, Subkhankulova T, Le Quesne JP, Coldwell MJ, Jopling CL, Belsham GJ et al.
Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and
the nuclear compartment. Nucleic Acids Res 2000; 28: 687–694.
16. Yuan S, Akey CW. Apoptosome structure, assembly, and procaspase activation. Structure
2013; 21: 501–515.
17. Xie Q, Bai Y, Wu J, Sun Y, Wang Y, Zhang Y et al. Methylation-mediated regulation of
E2F1 in DNA damage-induced cell death. J Recep Sign Trans 2011; 31: 139–146.
18. Shirsath NP, Manohar SM, Joshi KS. P276-00, a cyclin-dependent kinase inhibitor,
modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell
lines. Mol Cancer 2012; 11: 77: doi:10.1186/1476-4598-11-77.
19. Manohar SM, Rathos MJ, Sonawane V, Rao SV, Joshi KS. Cyclin-dependent kinase
inhibitor, P276-00 induces apoptosis in multiple myeloma cells by inhibition of Cdk9-T1 and
RNA polymerase II-dependent transcription. Leukemia Res 2011; 35: 821–830.
20. Komar AA, Hatzoglou M. Cellular IRES-mediated translation the war of ITAFs in
pathophysiological states. Cell Cycle 2011; 10: 229–240.
21. Spriggs KA, Bushell M, Mitchell SA, Willis AE. Internal ribosome entry segments-mediated
translation during apoptosis; the role of IRES-trans-acting factors. Cell Death Differ 2005;
12: 585–591.
22. Mitchell SA, Spriggs KA, Coldwell MJ, Jackson RJ, Willis AE. The Apaf-1 internal ribosome
entry segment attains the correct structural conformation for funcion via interactions with
PTB and unr 2003Mol Cell 11: 757–711.
23. Pickering BM, Mitchell SA, Spriggs KA, Stoneley M, Willis A E. BAG-1 internal ribosome
entry segment activity is promoted by structural changes mediated by poly (rC) binding
protein 1 and recruitment of polypyrimdine tract binding protein 1. Mol Cell Biol 2004; 24:
5595–5604.
24. Cobbold LC, Wilson LA, Sawicka K, King HA, Kondrashov AV, Spriggs KA et al.
Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from
increased interactions with and expression of PTB-1 and YB-1. Oncogene 2010; 29:
2884–2891.
25. Kaminsk A, Jackson R. The polypyrimidine tract binding protein requirement for internal
initiation of translation of cardiovirus RNAs is conditional rather than absolute. RNA 1998;
4: 626–628.
26. Kaminski A, Hunt SL, Patton JG, Jackson RJ. Direct evidence that polypyrimidine tract
binding protein (PTB) is essential for internal initiation of translation of encephalomyo-
carditis virus RNA. RNA 1995; 1: 924–938.
27. Gorospe M, Tominaga K, Wu X, Fahling M, Ivan M. Post-transcriptional control of
the hypoxic response by RNA-binding proteins and MicroRNAs. Front Mol Neurosci 2011;
4: 7.
28. Srikantan S, Gorospe M. HuR function in disease. Front Biosci Landmark 2012; 17:
189–205.
29. Pickering BM, Mitchell SA, Evans JR, Willis AE. Polypyrimidine tract binding protein and
poly (rC) binding protein 1 interact with the BAG-1 IRES and stimulate its activity in vitro
and in vivo. Nucleic Acids Res 2003; 31: 639–646.
30. Cobbold LC, Spriggs KA, Haines SJ, Dobbyn HC, Hayes C, de Moor CH et al. Identification
of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs.
Mol Cell Biol 2008; 28: 40–49.
31. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D et al.
Translational activation of snail1 and other developmentally regulated transcrip-
tion factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009;
15: 402–415.
32. Cammas A, Pileur F, Bonnal S, Lewis SM, Le´veˆque N, Holcik M et al. Cytoplasmic
relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation
of specific mRNAs. Mol Biol Cell 2007; 18: 5048–5059.
33. Jan E, Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of
cricket paralysis virus. J Mol Biol 2002; 324: 889–902.
34. Filbin ME, Kieft JS. Towards a structural understanding of IRES RNA function. Curr Opin
Struct Biol 2009; 19: 267–276.
35. Jan E, Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of
cricket paralysis virus. J Mol Biol 2002; 324: 889–902.
36. Xia X, Holcik M. Strong Eukaryotic IRESs Have Weak Secondary Structure. PLoS One
2009; 4: e4136.
37. Le Quesne JPC, Stoneley M, Fraser GA, Willis AE. Derivation of a structural Model for the
c-myc IRES. J Mol Biol 2001; 310: 111–126.
38. Jopling CL, Spriggs KA, Mitchell SA, Stoneley M, Willis AE. L-Myc protein synthesis is
initiated by internal ribosome entry. RNA 2004; 10: 287–298.
39. Jopling CL, Willis AE. N-myc translation is initiated via an internal ribosome entry
segment that displays enhanced activity in neuronal cells. Oncogene 2001; 20:
2664–2670.
40. Spriggs KA, Cobbold LC, Jopling CL, Cooper RE, Wilson LA, Stoneley M et al. Canonical
initiation factor requirements of the Myc family of internal ribosome entry segments.
Mol Cell Biol 2009; 29: 1565–1574.
41. Long JC, Caceres JF. The SR protein family of splicing factors: master regulators of gene
expression. Biochem J 2009; 417: 15–27.
42. Sanford JR, Gray NK, Beckmann K, Caceres JF. A novel role for shuttling SR proteins in
mRNA translation. Genes Dev 2004; 18: 755–768.
43. Michlewski G, Guil S, Semple CA, Caceres JF. Posttranscriptional regulation of miRNAs
harboring conserved terminal loops. Mol Cell 2008; 32: 383–393.
44. Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L et al. A death
effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in
mediating apoptotic cell death. Mol Cell 2012; 47: 291–305.
This work is licensed under a Creative Commons
Attribution 3.0 Unported License. To view a copy of
this license, visit http://creativecommons.org/licenses/by/3.0/
Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
Remodelling of a PTB complex is required for apoptotic IRES-mediated translation
HA King et al
171
Cell Death and Differentiation
